Natália Araújo has a PharmD (six-year curriculum program, Faculty of Pharmacy, University of Porto, 2001), and she was a research fellow at the Institute of Molecular Biology of the University of Porto. She worked as a community pharmacist at Porto for ten years. She decided to begin a carrer in Public Health research in 2014. She was a research fellow of the project NEON-BC: A five-year prospective cohort study on the neurological complications of breast cancer: frequency and impact in patient-reported outcomes (POCI-01-0145-FEDER-016867), and she was awarded a grant from the Foundation for Science and Technology (SFRH/BD/119390/2016) to carry out her Ph.D. thesis Longitudinal assessment of cognitive decline in breast and prostate cancer survivors, which she completed in 2021.
She is currently a co-supervisor of one Master’s dissertation and she is an integrated research member of the Laboratory for Integrative and Translational Research in Population Health (ITR; lab. LT4 ‘Patient and Population Outcomes Research: towards a precision approach to medicine and public health) .
